Literature DB >> 1539740

Cerebral metabolic responses and vasopressin and oxytocin secretions during progressive water deprivation in rats.

M Kadekaro1, J Y Summy-Long, S Freeman, J S Harris, M L Terrell, H M Eisenberg.   

Abstract

Progressive water deprivation increased plasma osmolality, plasma Na+ concentration, and hematocrit in proportion to the severity of dehydration. With increases of 2% in plasma osmolality (24 h dehydration), glucose utilization increased in the supraoptic nuclei and tended to increase in the neural lobe. With further dehydration, glucose utilization also increased in the paraventricular nuclei. These increases were paralleled by depletion of vasopressin and oxytocin contents in the neural lobe and by the enhanced secretion of both hormones into plasma, with a predominant increase of vasopressin. These changes were proportional to the degree of dehydration. With progression of dehydration, decreases in intracellular and extracellular volumes accentuate. Reductions in extracellular volume result in increased angiotensin II (ANG II) formation. Accordingly, glucose utilization in the subfornical organ (SFO), a primary site of ANG II action, increased after 48 and 72 h of dehydration. The median preoptic nucleus, which receives direct inputs from the SFO, also increased glucose utilization at these times. Glucose utilization also increased in the organum vasculosum laminae terminalis, probably in response to the converging inputs from osmoreceptors, volume receptors, and ANG II receptors. Decreases in glucose utilization were observed in the caudal and rostral ventrolateral medulla, perhaps as compensatory responses to decreased extracellular volume to prevent fall in arterial blood pressure.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1539740     DOI: 10.1152/ajpregu.1992.262.2.R310

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  6 in total

Review 1.  The facilitative glucose transporter GLUT3: 20 years of distinction.

Authors:  Ian A Simpson; Donard Dwyer; Daniela Malide; Kelle H Moley; Alexander Travis; Susan J Vannucci
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-06-24       Impact factor: 4.310

2.  Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors: predominant role of angiotensin III in the control of vasopressin release.

Authors:  S Zini; M C Fournie-Zaluski; E Chauvel; B P Roques; P Corvol; C Llorens-Cortes
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

3.  Vasopressin-independent targeting of aquaporin-2 by selective E-prostanoid receptor agonists alleviates nephrogenic diabetes insipidus.

Authors:  Emma T B Olesen; Michael R Rützler; Hanne B Moeller; Helle A Praetorius; Robert A Fenton
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-18       Impact factor: 11.205

Review 4.  Role of the Vasopressin/Apelin Balance and Potential Use of Metabolically Stable Apelin Analogs in Water Metabolism Disorders.

Authors:  Adrien Flahault; Pierre Couvineau; Rodrigo Alvear-Perez; Xavier Iturrioz; Catherine Llorens-Cortes
Journal:  Front Endocrinol (Lausanne)       Date:  2017-05-31       Impact factor: 5.555

Review 5.  Apelin and Vasopressin: The Yin and Yang of Water Balance.

Authors:  Pierre-Emmanuel Girault-Sotias; Romain Gerbier; Adrien Flahault; Nadia de Mota; Catherine Llorens-Cortes
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-22       Impact factor: 5.555

Review 6.  The Paraventricular Nucleus of the Hypothalamus in Control of Blood Pressure and Blood Pressure Variability.

Authors:  Bojana Savić; David Murphy; Nina Japundžić-Žigon
Journal:  Front Physiol       Date:  2022-03-16       Impact factor: 4.566

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.